Sublingual Microcirculation Data of Patients With Systemic Diseases
NCT ID: NCT02516215
Last Updated: 2016-10-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
360 participants
OBSERVATIONAL
2015-09-30
2017-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Population Research of Sublingual Microcirculation Data of Healthy Volunteers
NCT02359682
Sublingual Microcirculation of Healthy Volunteers by Using the Third Generation Microcirculation Video Microscope
NCT02412839
Machine Learning-assisted Analysis of Microcirculation Patterns and Parameters
NCT04957303
The Establishment of Tongue Examination Analysis From the Video Recording
NCT04923763
Application of Coronary Artery Chronic Total Occlusion Scoring Systems
NCT05883579
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1_Hypertension
Patients with diagnosed hypertension, without other systemic diseases
No intervention
2_Diabetes mellitus
Patients with diagnosed diabetes mellitus, without other systemic diseases
No intervention
3_Hypertension and diabetes mellitus
Patients with both diagnosed hypertension and diabetes mellitus
No intervention
4_end stage renal disease with hemodialysis
Patients with end stage renal disease with hemodialysis
No intervention
5_Peripheral arterial occlusive disease
Patients with disgnosed peripheral arterial occlusive disease
No intervention
6_Coronary artery disease
Patients with diagnosed coronary artery disease
No intervention
7_liver cirrhosis
Patients with diagnosed liver cirrhosis
No intervention
8_Anemia
Patients with diagnosed anemia
No intervention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI ranged from 18.5 to 27 kg/m2
* Presence of one of the condition
1. Diagnosed hypertenison \> 6 months, without other systemic diseases
2. Diagnosed diabetes mellitus \> 6 monthes, without other systemic diseases
3. Diagnosed with both hypertension and diabetes mellitus \> 6 months, without other systemic diseases
4. Diagnosed with end stage renal disease and recevied renal replacement therapy \> 6 months
5. Diagnosed with peripheral arterial occlusive diseases \> 6 months
6. Diagnosed with coronary artery disease \> 6 months
7. Diagnosed with liver cirrhosis \> 6 months
8. Diagnosed with anemia \> 6 months, hemoglobin level \< 10 g/dL
Exclusion Criteria
* Body temperature higher than 37.5 ℃ or lower than 35.5 ℃
* Any on of the following condition
1. Asthma
2. Chronic obstructive pulmonary disease
3. Endocrine diseases
4. Hematological disorders
5. Uncured cancer
6. Chronic uncured infection
7. Other major disease with limited daily activity
* Non-native speakers
20 Years
79 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Taiwan University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yu-Chang Yeh, M.D., Ph.D.
Role: PRINCIPAL_INVESTIGATOR
National Taiwan University Hospital, Department of Anesthesiology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Taiwan University Hospital, anesthesiology department
Taipei, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
201505008RINA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.